Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded to "Hold" by St

StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a research note released on Tuesday. Other analysts also recently issued reports about the stock. Raymond James initiated coverage on shares of Ionis Pharmaceuticals in a research report on Thursday, September 28th. They set a strong-buy […]

Related Keywords

United States , B Lynne Parshall , Piper Sandler , Raymond James , C Frank Bennett , Stifel Nicolaus , Securities Exchange Commission , Morgan Stanley , Horizon Investments , Ionis Pharmaceuticals Inc , News Ratings For Ionis Pharmaceuticals Daily , Almanack Investment Partners , Ionis Pharmaceuticals Stock Down , Ionis Pharmaceuticals , Goldman Sachs Group , Peoples Bank , Analyst Recommendations For Ionis Pharmaceuticals , Free Report , Pharmaceuticals Stock Down , Get Free Report , Directorb Lynne Parshall , Frank Bennett , Exchange Commission , Investment Partners , Financial Advisors , Ionis Pharmaceuticals Daily , Nasdaq Ions , Lions , Medical , 46433010 , Upgrade , Stocknews Com ,